#Healthcare businesses cannot afford to ignore the implications of #SEPs, #FRANDlicensing and their potential impact on their products and #IPstrategy.
February 2021
#Healthcare businesses cannot afford to ignore the implications of #SEPs, #FRANDlicensing and their potential impact on their products and #IPstrategy. We'll be discussing this in more detail in our #IPinHealthcare webinar tomorrow (9th February). Join us: zoom.us/webinar/regist… https://t.co/WSm2c9bPFc